European Journal of Epidemiology

, Volume 7, Issue 4, pp 403–422 | Cite as

Determinants of disease and disability in the elderly: The Rotterdam elderly study

  • A. Hofman
  • D. E. Grobbee
  • P. T. V. M. De Jong
  • F. A. Van den Ouweland
Epidemiological Projects: News


In this paper the Rotterdam Elderly Study is presented. The aim of the study is to investigate determinants of disease occurrence and progression in the elderly. In addition to contributing to our understanding of the etiology of geriatric illnesses, the study is expected to lead to specific recommendations for intervention. The study focusses on causally related determinants of major diseases in the elderly. Fields of interest for the Rotterdam Elderly Study are- conditions which interfere the most with the quality of life for the elderly. The aims of the Rotterdam Elderly Study are:
  1. (1)

    To investigate, by means of epidemiologic, clinical and basic research, the determinants of diseases in order to assess their etiologic significance.

  2. (2)

    To investigate potentially modifiable determinants in order to be able to develop preventive strategies by providing specific recommendations for intervention studies.


The Rotterdam Elderly Study focusses on four primary areas of research: neurogeriatric diseases, cardiovascular diseases, locomotor diseases and ophthalmologic diseases. It is a prospective follow-up study, in which determinants of disease and determintants of progression of disease will be investigated in the total population of 55 years or over of the district of Ommoord in Rotterdam. It is anticipated that about 1–0,000 people will participate in the study and they will be examined in the period of 1991 to 1995.

Key words

Aging Cohort study Determinants Disease Epidemiology Followup study 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    1.AclimandosW.A., GallowayN.R. Blindness in the City of Nottingham (1980–1985). Eye 1988; 2: 431–434.Google Scholar
  2. 2.
    Allaart C.F., Aronson D.C., Ruys Th, et al. Hereditary Protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1991 (in press).Google Scholar
  3. 3.
    3.AmaducciL.A., FratiglioniL., RoccaW.A., et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986; 36: 922–31.Google Scholar
  4. 4.
    Aspirin Myocardial Infarction Study Research Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661–9.Google Scholar
  5. 5.
    5.BerkumF.N.R.van, BirkenhdgerJ.C., vanVeenL.C.P., et al. Noninvasive axial and peripheral assessment of bone mineral content: A comparison between osteoporotic women and normal subjects. J Bone Min Res 1989; 4: 679–85.Google Scholar
  6. 6.
    Bijl R.V., Nederlands Centrum voor de Geestelijke Volksgezondheidszorg, Scenariorapport. Onderzoek Geestelijke Gezondheidszorg. STG publication, in press.Google Scholar
  7. 7.
    7.BinswangerO. Die Begrenzung der allgememen progessiven Paralysie. Berl Klin Wochenschr 1894; 31: 1103–5, 1137–9, 1180–6.Google Scholar
  8. 8.
    8.BoyceW.J.VesseyM.P. Rising incidence of fracture of the proximal femur. Lancet 1985; 1: 150–151.Google Scholar
  9. 9.
    Breslau P.J. Ultrasonic Duplex scanning in the evaluation of carotid artery disease. Maastricht: Thesis, 1982.Google Scholar
  10. 10.
    10.BriëtE., EngesserL., BrommerE.J.P., Broekmans A.W., BertinaR.M. Thrombophilia: its causes and a rough estimate of its prevalence. Thromb Haemost 1987; 58: 39–43Google Scholar
  11. 11.
    11.CannerP.L. Aspirin in coronary heart disease. Comparison of six clinical trials. Isr J Med Sci 1983; 19: 413–23.Google Scholar
  12. 12.
    Chandra V., Kohmen E., Schoenberg B.S. Head trauma with loss of conciousness as a risk factor for Alzheimer's disease using prospectively collected data. Neurology; 37: 152.Google Scholar
  13. 13.
    Claessens A.A.M.C., Schouten J.S.A.G., Vandenouweland F.A., Valkenburg H.A. Do clinical findings associate with radiographic osteoarthritis of the knee? Ann Rheum Dis 1991 (in press).Google Scholar
  14. 14.
    14.CobbS. The frequency of rheumatic diseases. Harvard Un Press 1971, Cambridge.Google Scholar
  15. 15.
    Consensus Committee. Consensus development conference: prophylaxis and treatment of osteoporosis. Br Med J 1987; 295: 914–1915Google Scholar
  16. 16.
    Consensus Conference. Differential diagnosis of dementing diseases. JAMA 1987; 258: 3411–6.Google Scholar
  17. 17.
    17.CoonW.W. Epidemiology of venous thromboembolism. Ann Surgery 1977; 186: 194–9.Google Scholar
  18. 18.
    18.CopelandJ.R.M., KellekerM.J., KellettJ.M., et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. Psychol Med 1976;6:439–49.Google Scholar
  19. 19.
    19.CummingsJ. Are patients with hip fractures more osteoporotic? Am J Med 1985; 78: 487–494.Google Scholar
  20. 20.
    20.CummingsS.R., KelseyJ.L., NevittM.C., O'Dowd K.J. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178–209.Google Scholar
  21. 21.
    21.DaviesM.J., ThomasA. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137–40.Google Scholar
  22. 22.
    Dewey M.E., Copeland J.R.M., Hofman A., eds. Case finding for dementia in epidemiological studies. Eurodem Report 1, Liverpool, 1990.Google Scholar
  23. 23.
    23.DuthieE.H., GlattS.L.. Understanding and treating multi-infarct dementia. Clin Geriatr Med 1988; 9: 749–66.Google Scholar
  24. 24.
    24.FerrisF.L. Senile macular degeneration: review of epidemiologic features. Am J Epidemiol 1983; 118: 132–151.Google Scholar
  25. 25.
    25.FitzgeraldD.J., RoyL., CatellaF., Fitz Gerald G.A. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983–9.Google Scholar
  26. 26.
    26.FowkesF.G.R. The measurement of atherosclerotic peripheral arterial disease in epidemilogical surveys. Int J Epidemiol 1988; 17: 248–54.Google Scholar
  27. 27.
    27.FriedL.P., BushT.L. Morbidity as a focus of preventive health care in the elderly. Epidemiol Rev 1988; 10: 48–64Google Scholar
  28. 28.
    28.FriesJ.F. Ageing, natural death and the compression of morbidity. N Engl J Med 1980; 303: 130–5.Google Scholar
  29. 29.
    29.FriesJ.F., GreenL.W., LevineS. Health Promotion and the compresion of morbidity. Lancet 1989; i: 481–3.Google Scholar
  30. 30.
    30.FusterV., Walter BowieE.J., LewisJ.C., Fass D.N., OwenC.A. Jr., BrownA.L. Resistance to arteriosclerosis in pigs with von Willebrand's disease. J Clin Invest 1978; 61: 722–730.Google Scholar
  31. 31.
    31.GhafourI.M., AllanD., FouldsW.S. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983; 67: 209–213.Google Scholar
  32. 32.
    32.GibsonJ.M., LaveryJ.R., RosenthalA.R.Blindness and partial sight in an elderly population. Br J Ophthalmol 1986; 70: 700–705.Google Scholar
  33. 33.
    33.GrobbeeDE. Hart en vaatziekten. In: Van der Maas PJ, Hofman A, Dekker E, ed. De epidemiologische basis van gezondheidsbeleid. Samson Stafleu: Alphen aan de Rijn, 1988.Google Scholar
  34. 34.
    34.Gunning-SchepersL.J., BarendregtJ.J., Van derMaasP.J. Population interventions reassessed. Lancet 1989; i: 479–81.Google Scholar
  35. 35.
    35.HachinskyV.C., LasserN.A., MarshallJ. Multiinfarct dementia: a cause of mental deterioration in the elderly. Lancet 1974; ii: 207–9–11.Google Scholar
  36. 36.
    36.HamstenA., WalldiusG., SzamosiA. et al. Plasminogen Activator Inhibitor in Plasma: Risk Factor for recurrent Myocardial Infarction. Lancet 1987; ii: 3–8.Google Scholar
  37. 37.
    Haynes S.G., Feinleib M., eds. The epidemiology of ageing. NIH publication 80-969, 1980.Google Scholar
  38. 38.
    38.HeanyR.P. Osteoporotic fracture space: a hypothesis. Bone Min 1989; 6: 1–13.Google Scholar
  39. 39.
    39.HendersonA.S. The epidemiology of Alzheimer's disease. Br Med Bull 1986; 42: 3–10.Google Scholar
  40. 40.
    40.HeptinstallS. Haematology, ethnography, and thrombosis. Br Med J 1987; 294: 3–4.Google Scholar
  41. 41.
    41.HeymanA., WilkonsonW.E., StaffordJ.A., et al. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984; 15: 335–41.Google Scholar
  42. 42.
    42.HofmanA., SchutteW., TanjaT.A. et al. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology 1989, 39: 1589–92.Google Scholar
  43. 43.
    Hofman A., Rocca W.A., Brayne C., et al. The prevalence of dementia in Europe. Int J Epidemiol 1991 (in press).Google Scholar
  44. 44.
    44.HoogendoornD. Enkele gegevens over 64.453 fracturen van het proximale uiteinde van het femur (collum plus trochantergebied) 1967–1979. Ned Tijdschr Geneeskd 1982; 126: 963–968Google Scholar
  45. 45.
    45.HuiS.L., WiskeP.S., NortonJ.A., JohnstonC.C. A prospective study of change in bone mass with age in post menopausal women. J Chron Dis 1982; 35: 715–725Google Scholar
  46. 46.
    46.HuseD.M., OsterG., KillenA.R., LaceyM.J., ColditzG.A. The economic costs of non-insulindependent diabetes mellitus. JAMA 1989; 262: 2708–13.Google Scholar
  47. 47.
    47.InzitariD., DiazF., FoxA. Vascular risk factors and leuco-araiosis. Arch Neurol 1985; 42: 951–9.Google Scholar
  48. 48.
    48.IsoM., FolsomA.R., WuK.K., et al. Hemostatic variables in Japanese and Caucasian men. Am J Epidemiol 1989; 130: 925–34.Google Scholar
  49. 49.
    Jonker C., Hooijer C. Seniele dementie type Alzheimer. Dissertation VU Amsterdam, 1986.Google Scholar
  50. 50.
    50.Juhan-VagueL, AlessiM.C., JolyP. et al. Plasma Plasminogen Activator Inhibitor-1 in Angina Pectoris. Influence of Plasma Insulin and acute-phase response. Arteriosclerosis 1989; 9: 362–66.Google Scholar
  51. 51.
    51.KannelW.B., WolfP.A., CastelliW.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease: The Framingham study. JAMA 1987; 258: 1183–6.Google Scholar
  52. 52.
    52.KannelW.B., WolfP.A., McGeeD.L., Dawber T.R., McNamaraP., CastelliW.P. Systolic blood pressure, arterial rigidity and risk of stroke: The Framingham study. JAMA 1981; 245: 1225–9.Google Scholar
  53. 53.
    53.KrolewskiA.S. Epidemiology of diabetes mellitus. In: Joslin's Diabetes Mellitus. Philadelphia: Lea & Febiger, 1985.Google Scholar
  54. 54.
    54.LechnerH., SchmidtR., BerthaG., JustichE., OffenbacherH., SchneiderG. Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. Stroke 1988; 19: 263–5.Google Scholar
  55. 55.
    55.LeibowitzH.M., KruegerD.E., MaunderL.R., et al. The Framingham Eye Study Monograph. An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Survey Ophthalmol 1980; 24: 335–610.Google Scholar
  56. 56.
    56.LeskeM.C. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983; 118: 166–191.Google Scholar
  57. 57.
    57.LevyD., GarrisonR.J., SavageD.D., KannelW.B., CastelliW.P. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Int Med 1989; 110: 101–7.Google Scholar
  58. 58.
    58.LevyD., AndersonK., SavageD.D., KannelW.B., ChristiansenJ.C., CastelliW.P. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. Ann Int Med 1988; 108: 7–13.Google Scholar
  59. 59.
    59.LoeligerE.A. Oral anticoagulation in the secondary prevention of myocardial infarction. Acta Med Scand 1981; 210 (S651): 305–15.Google Scholar
  60. 60.
    60.MazessR.B. On ageing bone loss. Clin Orthop Rel Res 1982; 165: 239–252.Google Scholar
  61. 61.
    61.McCormickJ. and SkrabauchP. Coronary heart disease is not preventable by population interventions. Lancet 1988; ii: 839–41.Google Scholar
  62. 62.
    62.McKhannG., DrachmanD., FolsteinM., et al. Clinical diagnosis of Alzheimer's disease. Neurology 1984; 34: 939–44.Google Scholar
  63. 63.
    63.MeadeT.W., NorthW.R.S. Population based distributions of haemostatic variables. Br Med Bull 1977; 33: 283–8.Google Scholar
  64. 64.
    64.MeadeT.W., NorthW.R.S., ChakrabartiR, et al. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; i: 1050–4.Google Scholar
  65. 65.
    65.MeadeT.W., MellowsS., BroznovicM., et al. Haemostatic function and ischaemic heart disease: Principal results of the Northwhick Park Heart Study. Lancet 1986; ii: 533–7.Google Scholar
  66. 66.
    66.MeierD.E., OrwollE.S., JonesJ.M. Marked disparity between trabecular and cortical bone loss with age in healthy men. Ann Int Med 1984; 101: 605–612.Google Scholar
  67. 67.
    67.MeltonJ.L., WahnerH.W., RichelsonL.S., O'FallonW.M., RiggsB.L. Osteoporosis and the risk of hip fracture. Am J Epidemiol 1986; 124: 254–261.Google Scholar
  68. 68.
    Merode van T. The use of a multi-gate pulsed Doppler system in the evaluation of the carotid artery circulation. Maastricht: Thesis, 1986.Google Scholar
  69. 69.
    69.MortimerJ., FrenchL.R., HuttonJ.T., et al. Head injury as a risk factor for Alzheimer's disease. Neurology 1985; 35: 264–7.Google Scholar
  70. 70.
    70.NevittM.P., BallardD.J., HallettJ.W. Prognosis of abdominal aortic aneurysms: A population based study. N Engl J Med 1989; 321: 1009–14.Google Scholar
  71. 71.
    71.Newton-JohnH.F., MorganD.B. The loss of bone with age, osteoporosis and fractures. Clin Orthop Rel Res 1970; 72: 229–252Google Scholar
  72. 72.
    72.NicholsT.C., BellingerD.A., JohnsonT.A., Lamb M.A., GriggsT.R. Von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circulation Res 1986; 59: 15–26.Google Scholar
  73. 73.
    Norris J.M., Dorman J.S., LaPorte R.E., et al. Clustering of premature mortality in 1,761 insulin-dependent diabetics and their family members.Google Scholar
  74. 74.
    74.OliverM.F. Prevention of coronary heart disease. Propaganda, promises, problems and prospects. Circulation 1986; 73: 1–9.Google Scholar
  75. 75.
    75.OsbornG.R. The incubation period of coronary thrombosis. London: Butterworths, 1963.Google Scholar
  76. 76.
    Persantin-Aspirin Reinfarction Study Research Group. Part 11. Secondary prevention with persantin and aspirin. J Am Coll Cardiol 1986; 7: 251–69.Google Scholar
  77. 77.
    77.PetoR., GrayR., CollinsR., WheatlyK., HennekensC., JarnzorikK., WarlowC., Hafner B., ThompsonE., NortonS., GillilandS., DollR. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 1988; 296: 313–6.Google Scholar
  78. 78.
    78.PleumeekersH., van derDoesE., GrobbeeD.E. Screening for abdominal aortic aneurysms. (Re) Ned Tijdschr Geneeskd 1989; 133: 1522.Google Scholar
  79. 79.
    Prevention of cardiovascular disease among the elderly. Report of a WHO meeting. World Health Organization: Geneva, 1987.Google Scholar
  80. 80.
    80.RaiszL.G., KreamB.E. Regulation of bone formation. N Engl J Med 1983; 309: 29–35;83–89.Google Scholar
  81. 81.
    81.ReavenG.M. Role of insulin resistance in human disease. Banting lecture. Diabetes 1988; 37: 1595–607.Google Scholar
  82. 82.
    82.RiggsB.L., MeltonL.J. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983; 75: 899–901.Google Scholar
  83. 83.
    83.RiggsB.L., MeltonL.J. Involutional osteoporosis. N Engl J Med 1986; 314: 1676–86Google Scholar
  84. 84.
    84.RiisB.J., ChristiansenC. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med 1988; 84: 646–653.Google Scholar
  85. 85.
    85.RobertsonD.A., HaleP.J., NattrassM. Macrovascular disease and hyperinsulinaemia. Bull Clin Endocrin Metab 1988; 2: 407–24.Google Scholar
  86. 86.
    86.RoccaW.A., AmaducciL.A., SchoenbergB.S. Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986; 19: 415–24.Google Scholar
  87. 87.
    87.RosendaalF.R. Life expectancy in hemophilia 1973–1986. Br J Haematol 1989; 71: 71–6.Google Scholar
  88. 88.
    88.RossR. The pathogenesis of atherosclerosis — an update. N Engl J Med 1986; 314: 488–500.Google Scholar
  89. 89.
    89.SaasseJ.L.C.M.van, VanRomundeL.K.J., Cats A., VandenbrouckeJ.P., ValkenburgH.A. Epidemiology of osteoarthritis: Zoetermeer Survey. Ann Rheum Dis 1989; 48: 271–80.Google Scholar
  90. 90.
    90.SalonenR., SolonenJ.T. Progression of carotid atherosclerosis and its determinants: A population-based ultrasonography study. Atherosclerosis 1990; 81: 33–40.Google Scholar
  91. 91.
    91.SchoenbergB.S., KokmenE., OhazakiH. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987; 22: 724–9.Google Scholar
  92. 92.
    Sixty Plus Reinfarction Study research group. A double-blind trial to assess longterm oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980: 989–993.Google Scholar
  93. 93.
    93.SlemendaC.W., JohnstonC.C. Bone Mass measurement: which site to measure. Am J Med 1988; 84: 643–645.Google Scholar
  94. 94.
    94.StahelinH.B. Senile dementia in relation to nutritional factors. Bibl Nutr Dieta 1986; 38: 136–44.Google Scholar
  95. 95.
    95.StolkR.P., GrobbeeD.E. Insulin and ischemic cardiovascular disease. J Drug Res 1990; 15: 165–9.Google Scholar
  96. 96.
    96.StoutR.W., CrawfordV. Active life expectancy and terminal dependency: Trends in long-term geriatric care over 33 years. Lancet 1988; i: 281–3.Google Scholar
  97. 97.
    97.StrasserT., ed. Cardiovascular care of the elderly. Geneva: World Health Organization, 1985.Google Scholar
  98. 98.
    98.SulkavaR., ErliunjunttiT., PaloJ. Head injury in Alzheimer's disease and vascular dementia. Neurology 1985;35:1530–1.Google Scholar
  99. 99.
    The Steering Committee of the Physicians Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321: 129–35.Google Scholar
  100. 100.
    The ARIL Investigators. The Atherosclerosis Risk in Communities (ARIL) Study: Design and Objectives. Am J Epidemiology 1989; 129: 687–702.Google Scholar
  101. 101.
    101.ThompsonS.G., DuckertF., HaverkateF. et al. The Measurement of Haemostasis factors in 16 European Laboratories: Quality Thrombosis and Haemostasis 1989; 61: 301–306.Google Scholar
  102. 102.
    102.TrouerbachW.Th., HoornstraK., Birkenhäger J.C., ZwambornA.W. Röntgendensitometric study of the phalanx. Diagn Im Clin Med 1985; 54: 64–77.Google Scholar
  103. 103.
    103.VroonhovenT.van. Screening for abdominal aortic anuerysms. Ned Tijdschr Geneeskd 1989; 133: 1061–2.Google Scholar
  104. 104.
    104.WattsE. Reduced fibrinolytic activity as cardiovascular disease risk-factor. Lancet 1986; ii: 809.Google Scholar
  105. 105.
    105.WelinL., SvärsudK., WilhelmsenL., LarssonB., TibblinG. Analysis of risk- factors for stroke in a cohort of men born in 1913. N Engl J Med 1987; 317: 521–6.Google Scholar
  106. 106.
    WHO.International Classification of Impairments, Disabilities and Handicaps. WHO, 1980, Geneva.Google Scholar
  107. 107.
    107.WilhelmsenL., SvarsuddK., Korsan-BengstenK., et al. Fibrinogen as a risk- factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–5.Google Scholar
  108. 108.
    108.WilsonD.B., GuyattG.H, StreinerD.L. The diagnosis of dementia. CMAJ 1987; 137: 625–9.Google Scholar

Copyright information

© Gustav Fischer 1991

Authors and Affiliations

  • A. Hofman
    • 1
  • D. E. Grobbee
    • 1
  • P. T. V. M. De Jong
    • 1
  • F. A. Van den Ouweland
    • 1
  1. 1.Department of Epidemiology & Biostatistics and Department of OphthalmologyErasmus University Medical SchoolDR RotterdamThe Netherlands

Personalised recommendations